Peter R. Dolan

AAA

DEFINITION of 'Peter R. Dolan'

A former CEO of Bristol-Myers. Dolan joined the company in 1988 and held various senior management positions, becoming president in 2000 and chairman in 2001, a position he held through 2005. Dolan was dismissed in September 2006 because of a patent dispute over the blood-thinning blockbuster drug Plavix, a major source of the company's revenues. The dispute led to major sales losses when a generic equivalent went on the market. Although he was fired, Dolan received a severance package worth $1.2 million and pension benefits worth about $9.5 million.

INVESTOPEDIA EXPLAINS 'Peter R. Dolan'

Born in 1956 in Massachusetts, Dolan earned his MBA from Dartmouth's Tuck School of Business in 1980. Privately-held Gemin X Pharmaceuticals appointed Dolan to its board in 2008. He has also served as chairman of the board of Pharmaceutical Research and Manufacturers of America (PhRMA).

RELATED TERMS
  1. John T. Chambers

    The president and CEO of Cisco Systems, a consumer electronics, ...
  2. Blockbuster Drug

    An extremely popular drug that generates annual sales of at least ...
  3. Chairman

    An executive elected by a company's board of directors that is ...
  4. Food And Drug Administration - ...

    A government agency established in 1906 with the passage of the ...
  5. Patent Share

    The percentage share of a universe of patents owned or created ...
  6. Corporate Governance

    The system of rules, practices and processes by which a company ...
Related Articles
  1. Evaluating The Board Of Directors
    Insurance

    Evaluating The Board Of Directors

  2. What Investors Can Learn From Insider ...
    Markets

    What Investors Can Learn From Insider ...

  3. Evaluating Pharmaceutical Companies
    Fundamental Analysis

    Evaluating Pharmaceutical Companies

  4. Get Tough On Management Puff
    Markets

    Get Tough On Management Puff

comments powered by Disqus
Hot Definitions
  1. Last In, First Out - LIFO

    An asset-management and valuation method that assumes that assets produced or acquired last are the ones that are used, sold ...
  2. Ghosting

    An illegal practice whereby two or more market makers collectively attempt to influence and change the price of a stock. ...
  3. Elasticity

    A measure of a variable's sensitivity to a change in another variable. In economics, elasticity refers the degree to which ...
  4. Tangible Common Equity - TCE

    A measure of a company's capital, which is used to evaluate a financial institution's ability to deal with potential losses. ...
  5. Yield To Maturity (YTM)

    The rate of return anticipated on a bond if held until the maturity date. YTM is considered a long-term bond yield expressed ...
  6. Net Present Value Of Growth Opportunities - NPVGO

    A calculation of the net present value of all future cash flows involved with an additional acquisition, or potential acquisition. ...
Trading Center